Condition
Sickle Cell Anemia clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Sickle Cell Anemia clinical trials that are recruiting, at sites in 11 countries (most in United States (6), Tanzania (2), Germany (2)). By phase: Phase 2 (3), Phase 3 (1), Phase 1/2 (1). There are also 28 NIH-funded research projects on Sickle Cell Anemia, with $10.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 28NIH research projects
- 11Countries
Newest Sickle Cell Anemia clinical trials
All recruiting trials (10)
-
Checking measles vaccine response in children with sickle cell disease
This study tests whether infants and young children with sickle cell disease develop enough protection in the weeks after their measles vaccine.
-
Senicapoc for Sickle Cell Disease with Hemolytic Phenotype
A mid-stage study tests whether daily senicapoc helps people with sickle cell disease who have ongoing red blood cell breakdown and low hemoglobin, despite hydroxyurea, by comparing it to a placebo over 24 weeks.
-
Tracking growth, puberty, fertility, and pregnancy in people with sickle cell anemia
This study will see if taking hydroxyurea changes growth, puberty, fertility, or pregnancy outcomes in people with sickle cell anemia.
-
Assessing pain tolerance, balance, and strength in children with sickle cell anemia
This study is testing how pain tolerance, balance, and muscle strength differ between healthy kids and those with sickle cell anemia to help create safe exercise guidelines for them.
-
Using alendronate to treat osteonecrosis in adults with sickle cell disease
This study is testing if a weekly medication called alendronate can help adults with sickle cell disease who have bone pain from osteonecrosis feel better and improve their bone health.
-
Evaluating a single dose of CTX001 for treating transfusion-dependent beta-thalassemia and severe sickle cell disease
This study is testing a single dose of a new treatment called CTX001 to see if it can help people with transfusion-dependent beta-thalassemia or severe sickle cell disease feel better.
-
Haploidentical stem cell transplantation for sickle cell disease
This study is testing a new type of stem cell transplant for people with sickle cell disease to see if it can cure the disease while causing fewer complications.
-
Understanding hydroxyurea effects during pregnancy and breastfeeding in women with sickle cell disease
This study looks at how taking hydroxyurea during pregnancy and breastfeeding affects women with sickle cell disease and their babies to better understand the risks and outcomes.
-
Transplanting stem cells from mismatched donors for sickle cell disease and other anemias
This study is testing if using stem cells from mismatched donors can help people with severe sickle cell disease and other anemias who don't have matching donors.
-
Collecting blood samples to study sickle cell disease
This study is collecting blood samples from healthy people and those with sickle cell disease to see if new drugs can help stop red blood cells from sickling.
NIH-funded research (28)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Hydroxyurea to help children with sickle cell anemia in Africa
A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.
-
Hydroxyurea for Children with Sickle Cell in Africa
A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.
-
Hydroxyurea for Children with Sickle Cell Disease in Africa
A safe and feasible use of hydroxyurea for young children with sickle cell disease in several African countries to reduce illness and improve daily life.
-
Hypoxemia during Sleep in Sickle Cell Disease: How Common is It and How Might Treatments Help
This study looks at how low oxygen during sleep affects adults with sickle cell disease and how they respond to therapy across multiple urban and rural sites.
-
Hypoxic red blood cells for sickle cell anemia using the Hemanext ONE system
A new approach using special low-oxygen red blood cells from the Hemanext ONE system is being tested to help adults and children with sickle cell anemia who rely on frequent transfusions.
-
Hydroxyurea for Children with Sickle Cell Anemia in Africa
A safety and feasibility pilot study tests giving hydroxyurea to young children with sickle cell anemia in sub-Saharan Africa to reduce illness and death.
-
Hydroxyurea for children with sickle cell anemia in sub‑Saharan Africa
This project gives hydroxyurea to young children with sickle cell anemia in sub‑Saharan Africa to find safe dosing and reduce sickle‑related complications.
-
Hydroxyurea for young children with sickle cell anemia in sub‑Saharan Africa
This project gives hydroxyurea to young children with sickle cell anemia in sub‑Saharan Africa to reduce painful crises, hospital stays, and early death.
-
Hydroxyurea for young children with sickle cell anemia in sub-Saharan Africa
Hydroxyurea is given to young children with sickle cell anemia in sub-Saharan Africa to improve health and reduce sickle-related complications.
-
Hydroxyurea treatment for young children with sickle cell anemia in Africa
Giving hydroxyurea to young children with sickle cell anemia in several African countries to reduce sickle-related problems while monitoring safety.
-
Hydroxyurea treatment for children with sickle cell anemia in sub-Saharan Africa
Hydroxyurea given to young children with sickle cell anemia in sub-Saharan Africa to reduce pain, infections, and early death.
-
A fast, at-a-glance genetic test for recently transfused sickle cell patients in low-resource settings
A new quick, inexpensive genetic test could give accurate sickle cell results right after a blood transfusion, even in low-resource clinics.
-
Ischemic and neurometabolomic contributors to brain health in sickle cell anemia
This grant studies why people with sickle cell anemia have cognitive problems, looking at brain blood flow, oxygen use, and other brain signals to understand who is at risk and why.
-
Hydroxyurea for children with sickle cell anemia in Africa
This project gives hydroxyurea to young children with sickle cell anemia in sub-Saharan Africa to help reduce pain crises, hospital visits, and early death while monitoring safety.
-
Predicting kidney disease worsening in adults with sickle cell anemia
Using computer learning to spot which adults with sickle cell anemia are most likely to have their kidney disease get worse.
-
A quick test for sickle cell anemia in children who have received blood transfusions
This project aims to create a fast, affordable test for sickle cell anemia in young children, especially those in areas with limited resources who have recently had a blood transfusion.
-
Understanding brain function and injury in children with sickle cell anemia
This study is looking at how stress on the body affects brain growth and thinking skills in kids with sickle cell anemia, even if they haven't had a stroke, to find ways to help them avoid long-term learning challenges.
-
Using flaxseed to reduce pain and inflammation in children with sickle cell anemia
This study is looking at whether adding flaxseed to the diet can help reduce pain caused by inflammation in children with sickle cell anemia, and it will involve giving some kids flaxseed products while others get a placebo to see how it affects their pain and gut health.
-
Understanding how oxygen supply affects brain development in children with sickle cell anemia
This study is looking at how the way oxygen is used in the brain affects children with sickle cell anemia, especially regarding their brain growth and development, to help improve their care and health outcomes.
-
Developing new drugs for Sickle Cell Anemia
This study is looking for new medicines to help people with Sickle Cell Disease by using a special imaging technique to find ways to stop red blood cells from sickling, which can lead to better health for patients.
-
Improving preventive care for children with sickle cell anemia
This study is looking to find out why many kids with sickle cell anemia aren't getting the check-ups and treatments they need, so we can come up with better ways to help them stay healthy and feel their best.
-
Using machine learning to predict kidney disease progression in sickle cell anemia
This study is looking at how computer models can help predict kidney problems in people with sickle cell anemia by checking things like protein levels in urine and genetic information, so we can find those who might need extra care early on to keep their kidneys healthy.
-
Investigating ovarian health in women with sickle cell anemia
This study is looking at how sickle cell anemia and its treatment with hydroxyurea might affect women's ability to have children, helping to provide important information for women with this condition about their reproductive health.
-
Understanding how the brain uses oxygen in sickle cell anemia patients
This study is looking at how well the brain uses oxygen in people with sickle cell anemia to understand why some may have silent strokes that could affect their thinking later on, and it aims to help doctors find those at greater risk for problems and improve their care.
-
Understanding spleen health in children with sickle cell anemia in sub-Saharan Africa
This study is looking at how sickle cell anemia affects the spleen in children living in sub-Saharan Africa, especially since they often have an enlarged spleen, and it will check how this changes before and after they take a medicine called hydroxyurea.
-
Investigating brain health in children with sickle cell anemia in Uganda
This study is looking at how sickle cell anemia affects children's brains in Uganda, especially focusing on hidden brain injuries that can impact their thinking and increase stroke risk, while also testing a treatment called hydroxyurea to help protect their brains over two and a half years.
-
Investigating the effects of hydroxyurea on brain health in children with sickle cell anemia in Uganda
This study is looking at how hydroxyurea treatment can help improve brain health and lower the chances of strokes in young children with sickle cell anemia in Uganda, and it will follow kids aged 2 to 9 over three years to see how the treatment affects their brain and overall health.
-
Screening for developmental delays in children with sickle cell disease
This study is looking at how sickle cell disease can affect the development and thinking skills of young children, so we can help kids aged 0-11 get the support they need early on to do better in school.
Related topics
Quick answers
How many Sickle Cell Anemia clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (6 trials), Tanzania (2 trials), Germany (2 trials), Ghana (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.